Target intelligence / Profile preview

14-3-3 protein zeta/delta (YWHAZ)

Target
YWHAZ
Molecular classification
Adapter protein, Scaffold protein, Other
01

Overview

14-3-3 protein zeta/delta (encoded by the YWHAZ gene) is a highly conserved, multifunctional adapter and scaffold protein belonging to the 14-3-3 family. It plays a critical role in regulating a wide array of cellular processes, including signal transduction, cell cycle progression, apoptosis, and cell survival, primarily by binding to phosphorylated serine or threonine motifs on target proteins. Through these interactions, it modulates the activity, localization, and stability of key signaling molecules such as AKT, RAF1, and BAD. In disease states, 14-3-3 protein zeta/delta is frequently overexpressed in various cancers (e.g., breast, lung, and gastric cancers), where it promotes tumor cell proliferation, metastasis, and chemoresistance. It is also implicated in neurodegenerative disorders like Alzheimer's disease, where it interacts with phosphorylated Tau, and in cardiovascular diseases such as cardiac hypertrophy. As a therapeutic target, it is addressed using protein-protein interaction (PPI) inhibitors (such as BV02, FOBISIN101, and difopein) or stabilizers (such as fusicoccin A) to selectively modulate its pathogenic interactions, though its widespread physiological roles present significant safety and toxicity challenges.

Other names
14-3-3 protein zetaTyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zetaProtein kinase C inhibitor protein 1KCIP-1YWHAD
02

Mechanism of action

Inhibition of protein-protein interactions (PPI) or stabilization of protein-protein interactions (molecular glue)

03

Biological functions

Signal transductionCell cycleApoptosisCell proliferationCell deathOther
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseOther
05

Safety considerations

Widespread physiological roles leading to potential off-target toxicityDisruption of essential cellular signaling pathways (PI3K/Akt, MAPK)Potential cardiotoxicity or neurotoxicity due to its role in cardiac and neuronal homeostasis
06

Interacting drugs

6 more in the full profile.

07

Biomarkers

YWHAZ expression levelPhosphorylated Tau14-3-3 protein levels in cerebrospinal fluid (CSF)

Beyond the preview

Go deeper on 14-3-3 protein zeta/delta (YWHAZ).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 14-3-3 protein zeta/delta (YWHAZ).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call